rs539653012
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_012470.4(TNPO3):c.2274-10delT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000403 in 1,611,888 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0022 ( 1 hom., cov: 31)
Exomes 𝑓: 0.00022 ( 1 hom. )
Consequence
TNPO3
NM_012470.4 intron
NM_012470.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.78
Publications
0 publications found
Genes affected
TNPO3 (HGNC:17103): (transportin 3) The protein encoded by this gene is a nuclear import receptor for serine/arginine-rich (SR) proteins such as the splicing factors SFRS1 and SFRS2. The encoded protein has also been shown to be involved in HIV-1 infection, apparently through interaction with the HIV-1 capsid protein. Several protein-coding and non-coding transcript variants have been found for this gene. [provided by RefSeq, Apr 2020]
TNPO3 Gene-Disease associations (from GenCC):
- autosomal dominant limb-girdle muscular dystrophy type 1FInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 7-128972591-GA-G is Benign according to our data. Variant chr7-128972591-GA-G is described in ClinVar as Benign. ClinVar VariationId is 284887.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00215 (328/152284) while in subpopulation AFR AF = 0.00768 (319/41544). AF 95% confidence interval is 0.00698. There are 1 homozygotes in GnomAd4. There are 159 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 328 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TNPO3 | NM_012470.4 | c.2274-10delT | intron_variant | Intron 18 of 22 | ENST00000265388.10 | NP_036602.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TNPO3 | ENST00000265388.10 | c.2274-10delT | intron_variant | Intron 18 of 22 | 1 | NM_012470.4 | ENSP00000265388.5 |
Frequencies
GnomAD3 genomes AF: 0.00216 AC: 328AN: 152166Hom.: 1 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
328
AN:
152166
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000668 AC: 166AN: 248544 AF XY: 0.000447 show subpopulations
GnomAD2 exomes
AF:
AC:
166
AN:
248544
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000221 AC: 322AN: 1459604Hom.: 1 Cov.: 30 AF XY: 0.000185 AC XY: 134AN XY: 726018 show subpopulations
GnomAD4 exome
AF:
AC:
322
AN:
1459604
Hom.:
Cov.:
30
AF XY:
AC XY:
134
AN XY:
726018
show subpopulations
African (AFR)
AF:
AC:
268
AN:
33388
American (AMR)
AF:
AC:
23
AN:
44418
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25992
East Asian (EAS)
AF:
AC:
0
AN:
39648
South Asian (SAS)
AF:
AC:
0
AN:
85878
European-Finnish (FIN)
AF:
AC:
0
AN:
53342
Middle Eastern (MID)
AF:
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
5
AN:
1110888
Other (OTH)
AF:
AC:
26
AN:
60284
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
16
33
49
66
82
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00215 AC: 328AN: 152284Hom.: 1 Cov.: 31 AF XY: 0.00214 AC XY: 159AN XY: 74450 show subpopulations
GnomAD4 genome
AF:
AC:
328
AN:
152284
Hom.:
Cov.:
31
AF XY:
AC XY:
159
AN XY:
74450
show subpopulations
African (AFR)
AF:
AC:
319
AN:
41544
American (AMR)
AF:
AC:
8
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
0
AN:
68032
Other (OTH)
AF:
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
16
33
49
66
82
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Dec 08, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Oct 16, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autosomal dominant limb-girdle muscular dystrophy type 1F Benign:1
Oct 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 9
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.